Enoxaparin

pharmacological · renal · Subcutaneous · IV

Enoxaparin. Low-molecular-weight heparin (~4500 Da average). Same antithrombin-mediated mechanism but biased toward factor Xa inhibition (Xa:IIa activity ratio ~3.8:1…

Low-molecular-weight heparin (~4500 Da average). Same antithrombin-mediated mechanism but biased toward factor Xa inhibition (Xa:IIa activity ratio ~3.8:1 vs UFH ~1:1). Predictable dose-response → no aPTT monitoring needed. Lower HIT incidence than UFH; preferred over UFH in most non-renal-failure scenarios.

mw_g_mol is deliberately LEFT EMPTY. The mean molecular weight is about 4500 Da (PMID:28635885), a real and often-quoted figure, but a third of the mass lies outside 2000-8000 Da and the chains clear at different rates, so filling the field would license mole-based arithmetic that has no physical meaning for a chain distribution. Note also that enoxaparin is dosed both in milligrams and in anti-Xa international units at roughly 100 IU per mg, a conversion this record never carried. If it is ever modelled again it should be as an anti-Xa activity record with explicit units, an explicit population and a renal-function caveat — the best-identified human estimate being 5.24 L and 5.0 h from data that included an IV bolus (PMID:12968985).

Sources: PMID:2851016, PMID:1963020, PMID:15961985, PMID:12968985